Alex Nguyen is an accomplished health care innovation specialist with over 5 years of experience in the life sciences sector. He excels at bridging the gap between startups, researchers, industry leaders, and clinical teams to drive meaningful growth and innovation. Alex specializes in supporting pharmaceutical and biotech companies during the critical preclinical research phase, providing tailored solutions that accelerate progress toward clinical trials.
His expertise in facilitating clinical validation and data access has helped numerous health tech companies transform promising concepts into practical applications. With a talent for connecting cutting-edge technologies with real-world clinical environments, Alex consistently helps organizations navigate the complex health care landscape. His collaborative approach and deep industry knowledge make him an invaluable partner in advancing healthcare solutions that improve patient outcomes and transform care delivery.
His expertise in facilitating clinical validation and data access has helped numerous health tech companies transform promising concepts into practical applications. With a talent for connecting cutting-edge technologies with real-world clinical environments, Alex consistently helps organizations navigate the complex health care landscape. His collaborative approach and deep industry knowledge make him an invaluable partner in advancing healthcare solutions that improve patient outcomes and transform care delivery.
Vikram Devdas is a seasoned engineer and accomplished entrepreneur with over 30 years of experience spanning networking semiconductor technology and health care innovation. He excels at identifying market opportunities and building successful ventures, having co-founded multiple companies including West Bay Semiconductor (acquired by Intel) and Blue Willow Systems (acquired by Philips).
As the Director of Medical Technology at Providence Health Care Ventures, he leverages his technical background and business acumen to advance health care solutions with real-world impact. Vik's extensive industry connections as a board member for several Silicon Valley startups and angel investor create valuable opportunities for collaboration and growth. His unique combination of technical depth, entrepreneurial vision, and health care insight makes him an invaluable guide for organizations navigating the complex intersection of technology and medicine.
As the Director of Medical Technology at Providence Health Care Ventures, he leverages his technical background and business acumen to advance health care solutions with real-world impact. Vik's extensive industry connections as a board member for several Silicon Valley startups and angel investor create valuable opportunities for collaboration and growth. His unique combination of technical depth, entrepreneurial vision, and health care insight makes him an invaluable guide for organizations navigating the complex intersection of technology and medicine.
Dr. Andrew Kestler is an emergency physician and public health expert with comprehensive training across healthcare administration, public health, and tropical medicine. He brings a unique multidisciplinary perspective to his work at St. Paul's and Vancouver General Hospitals, where he balances clinical practice with impactful research initiatives.
As the Vancouver Coastal Health Regional Emergency Department Addictions Lead, Dr. Kestler drives innovative interventions for patients with opioid use disorder, translating evidence-based approaches into practical solutions. His leadership within the Canadian Research Initiative on Substance Misuse (CRISM) amplifies his influence on substance use policy at local, regional, and national levels, addressing the complex challenges at the intersection of acute care and addiction medicine, ultimately improving outcomes for vulnerable patient populations.
As the Vancouver Coastal Health Regional Emergency Department Addictions Lead, Dr. Kestler drives innovative interventions for patients with opioid use disorder, translating evidence-based approaches into practical solutions. His leadership within the Canadian Research Initiative on Substance Misuse (CRISM) amplifies his influence on substance use policy at local, regional, and national levels, addressing the complex challenges at the intersection of acute care and addiction medicine, ultimately improving outcomes for vulnerable patient populations.
Dr. Scott Tebbutt is a molecular biologist and research leader whose career bridges fundamental science and clinical applications. He leverages his comprehensive background in biochemistry, genomics, and molecular biology to advance our understanding of diseases at the cellular level. As the Director of Research, Principal Investigator and Director of Education at the Centre for Heart Lung Innovation (HLI), and Chief Executive Officer of the Prevention of Organ Failure (PROOF) Centre of Excellence, Dr. Tebbutt applies his expertise across multiple domains. His pioneering work in biomarker development, particularly in transplant rejection and inflammatory disorders, exemplifies his commitment to translational medicine. Dr. Tebbutt's dual motivation—scientific curiosity coupled with improving patient care—drives his leadership in optimizing research infrastructure, enhancing cross-disciplinary training programs, and strategically positioning Providence Research for future innovation at the new St. Paul's Hospital Clinical Support and Research Centre.
